Highlights Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:44 2025-06-12 am EDT			5-day change	1st Jan Change
272.60 ^CHF	+1.00%		+1.83%	+6.69%

Jun. 11	US FDA approves Nuvation Bio's rare lung cancer drug	RE
Jun. 11	Roche Canada Says Health Canada Authorizes PiaSky	RE

Highlights

US FDA approves Nuvation Bio's rare lung cancer drug	Jun. 11	RE
Pharma Mar's Supplemental New Drug Application for Lung Cancer Drug Combo Gets US FDA Priority Review	Jun. 10	MT
Roche's Middle Eastern Arm Launches Sustainable Healthcare Lab Certification Initiative	Jun. 10	MT
Roche's Evrysdi Tablet Gets EU Clearance for Spinal Muscular Atrophy Treatment	Jun. 04	MT
EU Approves New Tablet Formulation for Roche's Spinal Muscular Atrophy Treatment	Jun. 04	MT
EU Approves Roche's Evrysdi Tablet For Spinal Muscular Atrophy	Jun. 04	MT
Pharmamar Announces Positive Results from the Phase 3Imforte Study of Zepzelca®? (Lurbinectedin) in Combination with Atezolizumab	Jun. 03	CI
Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer	May. 31	CI
WRAPUP 5-Trump officials downplay court ruling that blocked sweeping tariffs	May. 29	RE
EU Panel Backs Roche's Marketing Authorization Application for Breast Cancer Drug	May. 23	MT
EMA's CHMP Says Positive Opinion Was Adopted For Blenrep - Website	May. 23	RE
Roche: collaboration with Broad Clinical Labs	May. 23	CF
Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals	May. 23	RE
Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals	May. 23	RE
Roche: favorable follow-up data in LDGCB	May. 23	CF
Roche, Broad Clinical Labs Partner on Genome Sequencing Technology	May. 23	MT
Roche, Broad Clinical Labs Partner to Accelerate SBX Sequencing Adoption	May. 23	MT
Roche Announces New Collaboration With Broad Clinical Labs To Accelerate Adoption Of Cutting-Edge SBX Sequencing Technology	May. 23	RE
Roche's Susvimo Gets US FDA Clearance for Diabetic Retinopathy	May. 22	MT
Roche's Susvimo Gets US FDA Clearance for Diabetic Retinopathy	May. 22	MT
Genentech Provides Update on FDA Advisory Committee Meeting on Columvi Combination for People with Relapsed or Refractory Diffuse Large B-Cell Lymphoma	May. 20	CI
Weight-loss drug developers line up to tap lucrative market as competition heats up	May. 16	RE
US FDA Approves Roche's Companion Diagnostic Test for Non-small Cell Lung Cancer Treatment	May. 14	MT
Trump's Mandate for Lower Drug Prices Threatens Roche's Plans for US Investments	May. 14	MT
Roche: positive long-term data in breast cancer	May. 13	CF